The effect of a health care behavior promotion program to delay kidney deterioration in patients with chronic kidney disease stage 1-3a Phonsawan Hospital Nakhon Phanom Province
Keywords:
chronic kidney disease, health care behavior promotion, slowing down renal degenerationAbstract
This research is a quasi-experimental research. This quasi-experimental research aimed to study the effects of a health care behavior promotion program to delay renal deterioration in patients with chronic kidney disease stage 1-3a at Phonsawan Hospital. Nakhon Phanom Province This study was conducted in a group of chronic kidney disease stage 1-3a patients attending a chronic disease clinic. Primary and Holistic Services Group Phonsawan Hospital The study was conducted during May to July 2023 with 40 people comparing before and after receiving the program. of the sample, one-group type (one sample t-test design). The tools used for data collection were general information questionnaires and health information questionnaires. Health Belief Perception Assessment Form behavioral questionnaire for slowing renal degeneration. Data were analysis by descriptive statistics were used to find frequency, percentage, mean and standard deviation. and compared the data using Paired t-test statistics, the level of statistical significance was set at 0.05.
The results showed that 1) the perceived health belief patterns of CKD patients stage 1-3a of the post-experimental subjects had the mean scores of the perceived health belief patterns of patients with chronic kidney disease stage 1-3a. chronic kidney disease stage 1-3a more than before the experiment statistically significant at the 0.05 level (=87.03, S.D.=2.75;
=59.05, S.D.=3.09). After the experiment, the mean scores of behaviors to slow down renal deterioration of patients with chronic kidney disease stage 1-3a were higher than before the experiment. statistically significant at the 0.05 level (
= 114.50, S.D.=3.22;
= 91.05, S.D.=6.35) 3) Clinical outcomes It consisted of mean body mass index (BMI), blood glucose, blood pressure and glomerular filtration rates (eGFRs) of patients with chronic kidney disease stage 1-3a after the trial. test statistically significant at the 0.05 level (
= 21.28, S.D.=1.21;
= 23.57, S.D.=1.60;
= 7.01, S.D.=0.53;
= 8.97, S.D.=1.47;
= 123.65/75.70, S.D.=8.84/4.62;
= 144.68/92.48, S.D.=11.65/5.65;
= 129.60, S.D.=20.47;
= 202./25, S.D.=39.82;
= 86.25, S.D.=6.91;
= 73.03, S.D.=8.89 respectively).
